| |
| |
|
| Insider
Information: |
Landry Robert E |
| Relationship: |
EVP Finance CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,693 |
|
|
Indirect Shares
|
270 |
|
|
| Direct
Value |
$23,762,894 |
|
|
|
Indirect Value
|
$270,797 |
|
|
| Total
Shares |
23,963 |
|
|
| Total
Value |
$24,033,691 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-03 |
4 |
D |
$912.30 |
$627,662 |
D/D |
(688) |
22,448 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-07 |
4 |
AS |
$497.50 |
$346,271 |
D/D |
(696) |
24,373 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-08-04 |
4 |
AS |
$654.46 |
$455,504 |
D/D |
(696) |
23,973 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-11 |
4 |
D |
$664.34 |
$463,045 |
D/D |
(697) |
29,376 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-13 |
4 |
D |
$871.12 |
$629,820 |
D/D |
(723) |
21,361 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-02-03 |
4 |
AS |
$764.50 |
$564,966 |
D/D |
(739) |
32,105 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-27 |
4 |
OE |
$378.98 |
$284,235 |
D/D |
750 |
22,111 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-02-06 |
4 |
AS |
$783.05 |
$593,238 |
D/D |
(752) |
32,105 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-23 |
4 |
D |
$948.50 |
$736,036 |
D/D |
(776) |
23,308 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-10 |
4 |
AS |
$656.46 |
$520,477 |
D/D |
(781) |
29,957 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-24 |
4 |
D |
$406.59 |
$319,580 |
D/D |
(786) |
25,187 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-25 |
4 |
D |
$447.30 |
$357,840 |
D/D |
(800) |
25,387 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-12 |
4 |
OE |
$378.98 |
$303,184 |
D/D |
800 |
23,406 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-13 |
4 |
AS |
$505.60 |
$422,108 |
D/D |
(828) |
24,373 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-28 |
4 |
OE |
$378.98 |
$322,133 |
D/D |
850 |
22,419 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-15 |
4 |
AS |
$516.89 |
$442,276 |
D/D |
(853) |
24,373 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-08-31 |
4 |
D |
$675.03 |
$619,003 |
D/D |
(917) |
25,986 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-06-11 |
4 |
AS |
$607.50 |
$604,731 |
D/D |
(988) |
24,373 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-17 |
4 |
AS |
$540.70 |
$552,661 |
D/D |
(991) |
24,373 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-24 |
4 |
OE |
$272.70 |
$272,700 |
D/D |
1,000 |
25,973 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-25 |
4 |
OE |
$272.70 |
$272,700 |
D/D |
1,000 |
26,187 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-08-31 |
4 |
OE |
$555.67 |
$555,670 |
D/D |
1,000 |
26,903 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-13 |
4 |
OE |
$378.98 |
$378,980 |
D/D |
1,000 |
22,084 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-03-28 |
4 |
AS |
$818.81 |
$829,233 |
D/D |
(1,007) |
31,922 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-08 |
4 |
D |
$843.79 |
$854,759 |
D/D |
(1,013) |
30,686 |
0 |
- |
|
158 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
